{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:41:59Z","timestamp":1782751319528,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Internal Galatea Funding"},{"name":"Mexican FH Registry"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00831-9","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:19:11Z","timestamp":1763983151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of a deeply-phenotyped familial hypercholesterolemia cohort from Mexico shows a role for both rare and common alleles across known dyslipidemia genes and reveals structural variation in a novel locus"],"prefix":"10.1186","volume":"19","author":[{"given":"Nicholas","family":"Katsanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Mourtzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo D.","family":"Quinto-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandro J.","family":"Martagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"De La Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Gulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Ta Michael","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Lopez-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Moreno-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mas","family":"Montserrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00edriam","family":"Barrab\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel Salazar","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Moatamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela A.","family":"Galan-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Zubir\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Elias-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tusi\u00e9-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"F. H. Mexican Registry Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"5","key":"831_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11886-017-0848-8","volume":"19","author":"M Sharifi","year":"2017","unstructured":"Sharifi M, Futema M, Nair D, Humphries SE. Genetic Architecture of Familial Hypercholesterolaemia. Curr Cardiol Rep. 2017;19(5):44. https:\/\/doi.org\/10.1007\/s11886-017-0848-8.","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"831_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.atherosclerosis.2011.07.106","volume":"218","author":"A-B Garcia-Garcia","year":"2011","unstructured":"Garcia-Garcia A-B, et al. Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family. Atherosclerosis. 2011;218(2):423\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.07.106.","journal-title":"Atherosclerosis"},{"key":"831_CR3","doi-asserted-by":"crossref","unstructured":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217|European Heart Journal|Oxford Academic. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/academic.oup.com\/eurheartj\/article-abstract\/37\/17\/1384\/1748796?redirectedFrom=fulltext%26login=false","DOI":"10.1093\/eurheartj\/ehw028"},{"issue":"32","key":"831_CR4","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel M, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014;35(32):2146\u201357. https:\/\/doi.org\/10.1093\/eurheartj\/ehu274.","journal-title":"Eur Heart J"},{"issue":"45","key":"831_CR5","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/eht273.","journal-title":"Eur Heart J"},{"key":"831_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-025-10357-y","author":"C Lenin","year":"2025","unstructured":"Lenin C, et al. Facilitators and barriers to uptake of genetic and cascade testing in familial hypercholesterolemia: a systematic review. Int J Behav Med. 2025. https:\/\/doi.org\/10.1007\/s12529-025-10357-y.","journal-title":"Int J Behav Med"},{"issue":"9","key":"831_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016461","volume":"7","author":"LE Akioyamen","year":"2017","unstructured":"Akioyamen LE, et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open. 2017;7(9):e016461. https:\/\/doi.org\/10.1136\/bmjopen-2017-016461.","journal-title":"BMJ Open"},{"issue":"7","key":"831_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI107332","volume":"52","author":"JL Goldstein","year":"1973","unstructured":"Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. Part II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52(7):1544\u201368. https:\/\/doi.org\/10.1172\/JCI107332.","journal-title":"J Clin Invest"},{"key":"831_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2018.06.855","volume":"277","author":"AJ Vallejo-Vaz","year":"2018","unstructured":"Vallejo-Vaz AJ, Ray KK. Epidemiology of familial hypercholesterolaemia: community and clinical. Atherosclerosis. 2018;277:289\u201397. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.855.","journal-title":"Atherosclerosis"},{"key":"831_CR10","doi-asserted-by":"publisher","unstructured":"Hh H, Ms B, Jl G. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutation. 1992;1(6). https:\/\/doi.org\/10.1002\/humu.1380010602.","DOI":"10.1002\/humu.1380010602"},{"key":"831_CR11","doi-asserted-by":"publisher","first-page":"5936748","DOI":"10.1155\/2020\/5936748","volume":"2020","author":"T Teramoto","year":"2020","unstructured":"Teramoto T, et al. The prevalence and diagnostic ratio of familial hypercholesterolemia (FH) and proportion of acute coronary syndrome in Japanese FH patients in a healthcare record database study. Cardiovasc Ther. 2020;2020:5936748. https:\/\/doi.org\/10.1155\/2020\/5936748.","journal-title":"Cardiovasc Ther"},{"key":"831_CR12","unstructured":"\u201cThe Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population|Scientific Reports.\u201d Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/s41598-017-17181-9"},{"issue":"1","key":"831_CR13","doi-asserted-by":"publisher","first-page":"20459","DOI":"10.1038\/s41598-023-47692-7","volume":"13","author":"ACMGN de S\u00e1","year":"2023","unstructured":"de S\u00e1 ACMGN, Gomes CS, Prates EJS, Brant LCC, Malta DC. Prevalence and factors associated with possible cases of familial hypercholesterolemia in Brazilian adults: a cross-sectional study. Sci Rep. 2023;13(1):20459. https:\/\/doi.org\/10.1038\/s41598-023-47692-7.","journal-title":"Sci Rep"},{"issue":"5","key":"831_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jacl.2021.08.007","volume":"15","author":"TP Leren","year":"2021","unstructured":"Leren TP, Bogsrud MP. The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: results from twenty years of a national screening program in Norway. J Clin Lipidol. 2021;15(5):674\u201381. https:\/\/doi.org\/10.1016\/j.jacl.2021.08.007.","journal-title":"J Clin Lipidol"},{"issue":"no. 2","key":"831_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","volume":"24","author":"JR Chora","year":"2022","unstructured":"Chora JR, et al. The clinical genome resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification. Genet Med. 2022;24(2):293\u2013306. https:\/\/doi.org\/10.1016\/j.gim.2021.09.012.","journal-title":"Genet Med"},{"issue":"5","key":"831_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"831_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.atherosclerosis.2018.06.007","volume":"277","author":"R Mehta","year":"2018","unstructured":"Mehta R, et al. The development of the Mexican Familial Hypercholesterolemia (FH) National Registry. Atherosclerosis. 2018;277:517\u201323. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.06.007.","journal-title":"Atherosclerosis"},{"key":"831_CR18","unstructured":"Familial hypercholesterolemia in Mexico: initial insights from the national registry\u2014ScienceDirect. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S193328742030338X"},{"issue":"3","key":"831_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"key":"831_CR20","doi-asserted-by":"publisher","unstructured":"High resolution ancestry deconvolution for next generation genomic data|bioRxiv. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/doi.org\/10.1101\/2021.09.19.460980v1.abstract","DOI":"10.1101\/2021.09.19.460980v1.abstract"},{"issue":"no. 1","key":"831_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, et al. The ensembl variant effect predictor. Genome Biol. 2016;17(1):122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"831_CR22","doi-asserted-by":"publisher","unstructured":"Awan Z et al. APOE p.Leu167del mutation in familial hypercholesterolemia. Atherosclerosis. 2013;231(2):218\u2013222.https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.007","DOI":"10.1016\/j.atherosclerosis.2013.09.007"},{"key":"831_CR23","doi-asserted-by":"publisher","unstructured":"De La Vega FM, et al. Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases. Genome Med. 2021;13(1):153. https:\/\/doi.org\/10.1186\/s13073-021-00965-0.","DOI":"10.1186\/s13073-021-00965-0"},{"issue":"6","key":"831_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1363","volume":"43","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Oldridge DA, Diskin SJ, Zhang NR. CODEX: a normalization and copy number variation detection method for whole exome sequencing. Nucleic Acids Res. 2015;43(6):e39. https:\/\/doi.org\/10.1093\/nar\/gku1363.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"831_CR25","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28(21):2747\u201354. https:\/\/doi.org\/10.1093\/bioinformatics\/bts526.","journal-title":"Bioinformatics"},{"key":"831_CR26","doi-asserted-by":"publisher","unstructured":"Behera S et al. Comprehensive and accurate genome analysis at scale using DRAGEN accelerated algorithms. p. 2024.01.02.573821, Jan. 2024. https:\/\/doi.org\/10.1101\/2024.01.02.573821.","DOI":"10.1101\/2024.01.02.573821"},{"key":"831_CR27","doi-asserted-by":"publisher","unstructured":"Benchmarking of germline copy number variant callers from whole genome sequencing data for clinical applications|medRxiv. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/doi.org\/10.1101\/2024.07.12.24310338v1","DOI":"10.1101\/2024.07.12.24310338v1"},{"issue":"no. 8","key":"831_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen X, et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016;32(8):1220\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btv710.","journal-title":"Bioinformatics"},{"key":"831_CR29","unstructured":"Smit AFA, Hubley R, Green P. RepeatMasker. 2015 [Online]. Available http:\/\/www.repeatmasker.org"},{"issue":"3","key":"831_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310. https:\/\/doi.org\/10.1016\/S0022-2836(05)80360-2.","journal-title":"J Mol Biol"},{"key":"831_CR31","doi-asserted-by":"publisher","unstructured":"Hermjakob H et al. IntAct: an open source molecular interaction database. Nucleic Acids Res. 2004;32:D452\u2013D455. https:\/\/doi.org\/10.1093\/nar\/gkh052.","DOI":"10.1093\/nar\/gkh052"},{"issue":"3","key":"831_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"831_CR33","doi-asserted-by":"publisher","unstructured":"Wang K t al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17(11):1665\u201374. https:\/\/doi.org\/10.1101\/gr.6861907","DOI":"10.1101\/gr.6861907"},{"key":"831_CR34","unstructured":"The individual and global impact of copy-number variants on complex human traits\u2014ScienceDirect. Accessed: Feb. 05, 2025 [Online]. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002929722000611"},{"issue":"no. 1","key":"831_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jacl.2020.12.001","volume":"15","author":"R Mehta","year":"2021","unstructured":"Mehta R, et al. Familial hypercholesterolemia in Mexico: initial insights from the national registry. J Clin Lipidol. 2021;15(1):124\u201333. https:\/\/doi.org\/10.1016\/j.jacl.2020.12.001.","journal-title":"J Clin Lipidol"},{"key":"831_CR36","unstructured":"Mexican Biobank advances population and medical genomics of diverse ancestries. Nature. Accessed: Feb. 07, 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/s41586-023-06560-0"},{"key":"831_CR37","doi-asserted-by":"publisher","unstructured":"Sohail M, et al. Mexican Biobank advances population and medical genomics of diverse ancestries. Nature. 2023;622(7984):775\u201383. https:\/\/doi.org\/10.1038\/s41586-023-06560-0.","DOI":"10.1038\/s41586-023-06560-0"},{"key":"831_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.574474","author":"M Vrablik","year":"2020","unstructured":"Vrablik M, Tich\u00fd L, Freiberger T, Blaha V, Satny M, Hubacek JA. Genetics of familial hypercholesterolemia: new insights. Front Genet. 2020. https:\/\/doi.org\/10.3389\/fgene.2020.574474.","journal-title":"Front Genet"},{"issue":"6","key":"831_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jacl.2019.09.009","volume":"13","author":"Z Petrulioniene","year":"2019","unstructured":"Petrulioniene Z, Gargalskaite U, Mikstiene V, Norvilas R, Skiauteryte E, Utkus A. Autosomal recessive hypercholesterolemia: case report. J Clin Lipidol. 2019;13(6):887\u201393. https:\/\/doi.org\/10.1016\/j.jacl.2019.09.009.","journal-title":"J Clin Lipidol"},{"key":"831_CR40","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1590\/S0036-36342010000700008","volume":"52","author":"CA Aguilar-Salinas","year":"2010","unstructured":"Aguilar-Salinas CA, G\u00f3mez-P\u00e9rez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52:S44\u201353.","journal-title":"Salud Publica Mex"},{"key":"831_CR41","doi-asserted-by":"publisher","unstructured":"Chora JR, Medeiros AM, Alves AC, Bourbon M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med. 2018;20(6):591\u2013598.https:\/\/doi.org\/10.1038\/gim.2017.151","DOI":"10.1038\/gim.2017.151"},{"issue":"no. 2","key":"831_CR42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2011.06.006","volume":"218","author":"G Vaca","year":"2011","unstructured":"Vaca G, et al. Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia. Atherosclerosis. 2011;218(2):391\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.006.","journal-title":"Atherosclerosis"},{"key":"831_CR43","doi-asserted-by":"publisher","unstructured":"Medeiros AM, Alves AC, Francisco V, Bourbon M, Investigators of the Portuguese FH Study. Update of the Portuguese Familial Hypercholesterolaemia study. Atherosclerosis. 2010;212(2):553\u201358.https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.07.012","DOI":"10.1016\/j.atherosclerosis.2010.07.012"},{"issue":"2","key":"831_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1258\/acb.2007.007077","volume":"45","author":"KE Liyanage","year":"2008","unstructured":"Liyanage KE, Hooper AJ, Defesche JC, Burnett JR, Van Bockxmeer FM. High- resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations. Ann Clin Biochem. 2008;45(2):170\u20136. https:\/\/doi.org\/10.1258\/acb.2007.007077.","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"831_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"MA Austin","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160(5):407\u201320. https:\/\/doi.org\/10.1093\/aje\/kwh236.","journal-title":"Am J Epidemiol"},{"key":"831_CR46","doi-asserted-by":"publisher","unstructured":"Khalil YA, Rab\u00e8s J-P, Boileau C, Varret M. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11\u201322.https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.05.007","DOI":"10.1016\/j.atherosclerosis.2021.05.007"},{"issue":"1\u20132","key":"831_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00439-004-1192-9","volume":"116","author":"S Canizales-Quinteros","year":"2005","unstructured":"Canizales-Quinteros S, et al. A novel ARH splice site mutation in a Mexican kindred with autosomal recessive hypercholesterolemia. Hum Genet. 2005;116(1\u20132):114\u201320. https:\/\/doi.org\/10.1007\/s00439-004-1192-9.","journal-title":"Hum Genet"},{"issue":"no. 11","key":"831_CR48","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1194\/jlr.D079301","volume":"58","author":"MA Iacocca","year":"2017","unstructured":"Iacocca MA, et al. Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia. J Lipid Res. 2017;58(11):2202\u20139. https:\/\/doi.org\/10.1194\/jlr.D079301.","journal-title":"J Lipid Res"},{"issue":"no. 10","key":"831_CR49","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.cjca.2018.07.479","volume":"34","author":"MA Iacocca","year":"2018","unstructured":"Iacocca MA, et al. Whole-gene duplication of PCSK9 as a novel genetic mechanism for severe familial hypercholesterolemia. Can J Cardiol. 2018;34(10):1316\u201324. https:\/\/doi.org\/10.1016\/j.cjca.2018.07.479.","journal-title":"Can J Cardiol"},{"issue":"3","key":"831_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ecl.2022.02.006","volume":"51","author":"WJ Loh","year":"2022","unstructured":"Loh WJ, Watts GF. The inherited hypercholesterolemias. Endocrinol Metab Clin North Am. 2022;51(3):511\u201337. https:\/\/doi.org\/10.1016\/j.ecl.2022.02.006.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"831_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2003.11.009","volume":"172","author":"L Pisciotta","year":"2004","unstructured":"Pisciotta L, et al. Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. Atherosclerosis. 2004;172(2):309\u201320. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2003.11.009.","journal-title":"Atherosclerosis"},{"issue":"8","key":"831_CR52","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/ATVBAHA.124.320774","volume":"44","author":"B Verg\u00e8s","year":"2024","unstructured":"Verg\u00e8s B, et al. Hypertriglyceridemia results from an impaired catabolism of triglyceride-rich lipoproteins in PLIN1-related lipodystrophy. Arterioscler Thromb Vasc Biol. 2024;44(8):1873\u201383. https:\/\/doi.org\/10.1161\/ATVBAHA.124.320774.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"831_CR53","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/ATVBAHA.120.314168","volume":"40","author":"JS Dron","year":"2020","unstructured":"Dron JS, et al. Loss-of-function CREB3L3 variants in patients with severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2020;40(8):1935\u201341. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314168.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"831_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cge.14036","volume":"100","author":"MD Di Taranto","year":"2021","unstructured":"Di Taranto MD, et al. Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: implications for diagnosis improvement. Clin Genet. 2021;100(5):529\u201341. https:\/\/doi.org\/10.1111\/cge.14036.","journal-title":"Clin Genet"},{"issue":"52","key":"831_CR55","doi-asserted-by":"publisher","first-page":"52820","DOI":"10.1074\/jbc.M310482200","volume":"278","author":"O Kocher","year":"2003","unstructured":"Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, Krieger M. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism*. J Biol Chem. 2003;278(52):52820\u20135. https:\/\/doi.org\/10.1074\/jbc.M310482200.","journal-title":"J Biol Chem"},{"key":"831_CR56","unstructured":"Exploring and visualizing large-scale genetic associations by using PheWeb. Nature Genetics. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/s41588-020-0622-5"},{"issue":"12","key":"831_CR57","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/2047487319871733","volume":"27","author":"SU Khan","year":"2020","unstructured":"Khan SU, et al. Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: systematic review and meta-analysis of trials. Eur J Prev Cardiol. 2020;27(12):1255\u201368. https:\/\/doi.org\/10.1177\/2047487319871733.","journal-title":"Eur J Prev Cardiol"},{"key":"831_CR58","first-page":"53","volume":"3","author":"I De Castro-Or\u00f3s","year":"2010","unstructured":"De Castro-Or\u00f3s I, Pocov\u00ed M, Civeira F. \u201cThe genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.\u201d Appl Clin Genet. 2010;3:53\u201364.","journal-title":"Appl Clin Genet"},{"issue":"no. 12","key":"831_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1007","volume":"7","author":"KHY Wong","year":"2019","unstructured":"Wong KHY, et al. Three patients with homozygous familial hypercholesterolemia: genomic sequencing and kindred analysis. Mol Genet Genomic Med. 2019;7(12):e1007. https:\/\/doi.org\/10.1002\/mgg3.1007.","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"831_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacl.2018.02.015","volume":"12","author":"TDJ Hern\u00e1ndez Flores","year":"2018","unstructured":"Hern\u00e1ndez Flores TDJ, et al. Screening of LDLR and APOB gene mutations in Mexican patients with homozygous familial hypercholesterolemia. J Clin Lipidol. 2018;12(3):693\u2013701. https:\/\/doi.org\/10.1016\/j.jacl.2018.02.015.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"831_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.arcmed.2005.04.018","volume":"37","author":"L Robles-Osorio","year":"2006","unstructured":"Robles-Osorio L, et al. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch Med Res. 2006;37(1):102\u20138. https:\/\/doi.org\/10.1016\/j.arcmed.2005.04.018.","journal-title":"Arch Med Res"},{"issue":"2","key":"831_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ymgme.2010.11.006","volume":"102","author":"AC Fahed","year":"2011","unstructured":"Fahed AC, et al. Homozygous familial hypercholesterolemia in Lebanon: a genotype\/phenotype correlation. Mol Genet Metab. 2011;102(2):181\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2010.11.006.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"831_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jacl.2016.11.004","volume":"11","author":"RD Santos","year":"2017","unstructured":"Santos RD, et al. Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries. J Clin Lipidol. 2017;11(1):160\u20136. https:\/\/doi.org\/10.1016\/j.jacl.2016.11.004.","journal-title":"J Clin Lipidol"},{"issue":"no. 1","key":"831_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/geno.1997.4898","volume":"45","author":"NB Myant","year":"1997","unstructured":"Myant NB, Forbes SA, Day INM, Gallagher J. Estimation of the age of the ancestral Arginine3500\u2192 Glutamine mutation in human ApoB-100. Genomics. 1997;45(1):78\u201387. https:\/\/doi.org\/10.1006\/geno.1997.4898.","journal-title":"Genomics"},{"key":"831_CR65","unstructured":"Update of the Portuguese Familial Hypercholesterolaemia Study. Abstract, Europe PMC. Accessed: Feb. 05, 2025. [Online]. Available: https:\/\/europepmc.org\/article\/med\/20828696"},{"issue":"8","key":"831_CR66","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/humu.24360","volume":"43","author":"J Corominas","year":"2022","unstructured":"Corominas J, et al. Clinical exome sequencing-mistakes and caveats. Hum Mutat. 2022;43(8):1041\u201355. https:\/\/doi.org\/10.1002\/humu.24360.","journal-title":"Hum Mutat"},{"issue":"5","key":"831_CR67","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1210\/jc.2015-3874","volume":"101","author":"A Cenarro","year":"2016","unstructured":"Cenarro A, et al. The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes. J Clin Endocrinol Metab. 2016;101(5):2113\u201321. https:\/\/doi.org\/10.1210\/jc.2015-3874.","journal-title":"J Clin Endocrinol Metab"},{"key":"831_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2019.01.024","volume":"282","author":"AM Bea","year":"2019","unstructured":"Bea AM, et al. Lipid-lowering response in subjects with the p. (Leu167del) mutation in the APOE gene. Atherosclerosis. 2019;282:143\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.024.","journal-title":"Atherosclerosis"},{"issue":"22","key":"831_CR69","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","volume":"67","author":"AV Khera","year":"2016","unstructured":"Khera AV, et al. Diagnostic yield of sequencing familial hypercholesterolemia genes in severe hypercholesterolemia. J Am Coll Cardiol. 2016;67(22):2578\u201389. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.520.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"831_CR70","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1177\/2047487319829746","volume":"26","author":"S Lee","year":"2019","unstructured":"Lee S, Akioyamen LE, Aljenedil S, Rivi\u00e8re J-B, Ruel I, Genest J. Genetic testing for familial hypercholesterolemia: impact on diagnosis, treatment and cardiovascular risk. Eur J Prev Cardiol. 2019;26(12):1262\u201370. https:\/\/doi.org\/10.1177\/2047487319829746.","journal-title":"Eur J Prev Cardiol"},{"key":"831_CR71","doi-asserted-by":"publisher","unstructured":"Talmud PJ et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet. 2013;381(9874):1293\u20131301. https:\/\/doi.org\/10.1016\/S0140-6736(12)6212-8","DOI":"10.1016\/S0140-6736(12)6212-8"},{"issue":"5","key":"831_CR72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCGEN.120.002919","volume":"13","author":"M Trinder","year":"2020","unstructured":"Trinder M, et al. Polygenic contribution to low-density lipoprotein cholesterol levels and cardiovascular risk in monogenic familial hypercholesterolemia. Circ Genom Precis Med. 2020;13(5):515\u201323. https:\/\/doi.org\/10.1161\/CIRCGEN.120.002919.","journal-title":"Circ Genom Precis Med"},{"key":"831_CR73","doi-asserted-by":"publisher","unstructured":"Ketharnathan S et al. A non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression. Hum Mol Genet. 2018;27(22):3964\u20133973. https:\/\/doi.org\/10.1093\/hmg\/ddy295.","DOI":"10.1093\/hmg\/ddy295"},{"issue":"4","key":"831_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040605","volume":"12","author":"HG Choi","year":"2022","unstructured":"Choi HG, et al. Association between gout and dyslipidemia: a nested case-control study using a national health screening cohort. J Pers Med. 2022;12(4):605. https:\/\/doi.org\/10.3390\/jpm12040605.","journal-title":"J Pers Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00831-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:19:16Z","timestamp":1763983156000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00831-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00831-9","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research protocol has been approved by the Institutional Research and Ethics Committees (Institutional Review Board, IRB) of the National Institute of Health Sciences and Nutrition \"Salvador Zubir\u00e1n\", in Mexico City, under reference number 2571. The sample identifiers used in this study are known only to the research team and do not correspond to any identifiers recognized by individuals outside the study, including hospital staff or participants themselves.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"CDQC, NM, ALP, SMG, DM, MB, DB, PSF, JW, BM, JG, MTML, MAF, AGI, FMDLV, CDB, and NK are or were employees or contractors from Galatea Bio, Inc. Theremaining authors declare no conflict of interest regarding the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Individual-level data used in this research were collected in a healthcare setting and are subject to controlled access for privacy reasons. The ethics committee and\/or informed consent does not allow for public availability. This research has been conducted using the UK Biobank Resource under Application Number 89006.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}}],"article-number":"141"}}